Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

NCT04610229 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Azienda USL Reggio Emilia - IRCCS